Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05024695 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Study acronym: STAR-V
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 37 of 37 sites
    v5
  3. Site details revised at 6 of 37 sitesv4
  4. Trial status: Active, Not Recruiting to Recruiting
    • Study sites: 27 to 37
    v3
  5. Primary completion date: Mar 2025 to Jul 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 1 to 27
    • Study completion date: Mar 2027 to Jul 2029
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.
Trial Details
NCT Number NCT05024695
Lead Sponsor iSTAR Medical
Conditions
(from sponsor)		 Glaucoma
Related terms Choroidal Effusions, Glaucoma, Glaucoma, Open-Angle
Enrollment 975 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov